Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Pierre Fabre announce 1st Patient Dosed in Phase I/II of PFL-002/VERT-002, a targeted therapy in NSCLC with MET Alterations 2024-10-24 15:15
Founder of Hua Medicine Dr. Li CHEN was awarded the "C.C. Tan Life Science Industrialization Award" 2024-10-24 13:16
J INTS BIO Presents Interim Findings from Phase 1/2 Clinical Trial of 4th-Generation EGFR-TKI 'JIN-A02' in NSCLC: A Potential Breakthrough in Overcoming Acquired Resistance to Targeted Therapy 2024-10-24 12:42
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation 2024-10-24 08:08
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent 2024-10-24 06:02
Caliway Completed CBL-514 Phase 2b Study (CBL-0205) for Subcutaneous Fat Reduction 2024-10-24 01:42
CCTV+: Explore the Wizard of Oz in Jiangzhong Pharmaceutical Valley 2024-10-23 15:38
Samsung Biologics reports third quarter 2024 financial results 2024-10-23 14:55
Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals 2024-10-22 18:57
Minghui Pharmaceutical Inc. Announces Positive Topline Results from Phase Ib/II Clinical Trial of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Patients with Active, Moderate-to-Severe Thyroid Eye Disease (TED) 2024-10-22 18:00
HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure 2024-10-22 13:47
Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON® Global Phase 3 NefIgArd Clinical Trial Published in "Kidney 360" Magazine 2024-10-22 07:40
Moleac Announces PT Ferron Par Pharmaceuticals as New Exclusive Partner in Indonesia 2024-10-21 22:20
Great Bay Bio Intelligent Drug Development Ecosystem Officially Launched 2024-10-21 13:57
Everest Medicines Announces Taiwan TFDA Approval of NEFECON® for the Treatment of Primary IgA Nephropathy 2024-10-21 07:40
Hong Kong Breast Cancer Foundation "Pink Walk 2024" Charity Walk Concluded Successfully 2024-10-20 17:23
MicuRx Pharmaceuticals Showcases the Pipeline Status of MRX-5 and MRX-8 at BIO Investor Forum 2024-10-18 22:09
Xinhua Silk Road: 55th Zhangshu National Traditional Chinese Materia Medica Trade Fair held in E. China's Jiangxi 2024-10-18 20:23
LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing 2024-10-18 18:00
111 to Announce Third Quarter 2024 Unaudited Financial Results on November 28, 2024 - Conference Call to Follow 2024-10-18 17:00
1 6 7 8 9 10 412